|
"tan m"的相關文件
顯示項目 26-36 / 36 (共2頁)
<< < 1 2
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T05:14:33Z |
ErbB2 promotes Src synthesis and stability: Novel mechanisms of Src activation that confer breast cancer metastasis
|
Tan, M.;Li, P.;Klos, K.S.;Lu, J.;Lan, K.-H.;Nagata, Y.;Fang, D.;Jing, T.;Yu, D.; KENG-HSUEH LAN |
| 臺大學術典藏 |
2018-09-10T04:46:08Z |
PTEN key to Herceptin response in Her2-positive breast cancer
|
Yu, D.;Nagata, Y.;Lan, K.-H.;Zhou, X.;Tan, M.;Sahin, A.A.;Klos, K.S.;Li, P.;Nguyen, N.T.;Hortobagyi, G.N.;Hung, M.-C.;Monia, B.P.;Jensen, N.;Dedeaux, S.;Esteva, F.; KENG-HSUEH LAN |
| 臺大學術典藏 |
2018-09-10T04:46:08Z |
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|
Nagata, Y.;Lan, K.-H.;Zhou, X.;Tan, M.;Esteva, F.J.;Sahin, A.A.;Klos, K.S.;Li, P.;Monia, B.P.;Nguyen, N.T.;Hortobagyi, G.N.;Hung, M.-C.;Yu, D.; KENG-HSUEH LAN |
| 臺大學術典藏 |
2018-09-10T04:46:08Z |
Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers
|
Zhou, X.;Tan, M.;Hawthorne, V.S.;Klos, K.S.;Lan, K.-H.;Yang, Y.;Yang, W.;Smith, T.L.;Shi, D.;Yu, D.; KENG-HSUEH LAN |
| 臺大學術典藏 |
2018-09-10T04:07:03Z |
Phosphorylation on tyrosine-15 of p34Cdc2 by ErbB2 inhibits p34Cdc2 activation and is involved in resistance to taxol-induced apoptosis
|
Tan, M.;Jing, T.;Lan, K.-H.;Neal, C.L.;Li, P.;Lee, S.;Fang, D.;Nagata, Y.;Liu, J.;Arlinghaus, R.;Hung, M.-C.;Yu, D.; KENG-HSUEH LAN |
| 臺大學術典藏 |
2015 |
Epithelial-mesenchymal transition driven by transcriptional feedback loops contributes to intertumoral molecular heterogeneity in the metastasis and relapse of epithelial ovarian cancer
|
RUBY YUN-JU HUANG; Thiery, JP; Ye, J; Kuay, KT; Tan, TZ; Tan, M; Chung, VY; Chung, Vy;Tan, M;Tan, Tz;Kuay, Kt;Ye, J;Thiery, Jp;Ruby Yun-Ju Huang |
| 亞洲大學 |
2010 |
ARD1 stabilization of TSC2 suppresses tumorigenesis via the mTOR signaling pathway
|
;Kuo, H-P;Lee, D-F;Chen, C-T;Liu, M;Chou, C-K;Lee, H-J.;Xie, X;Wei, Y.;Xia, W;Zhang, W;Yi, D;Yang, J-Y;Huang, T-H;Yen, C-J;Tan, M;Xing, G;Zhao, Y;Lin, C-H;Tsai, S-F;Fidler, IJ;洪明奇;Hung, Mien-Chie |
| 中國醫藥大學 |
2010 |
ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway
|
(Kuo, H-P); (Lee, D-F); (Chen, C-T.); (Liu, M.); (Chou, C-K.); (Lee, H. J.); (Xie, X.); (Wei, Y.); (Xia, W); (Zhang, W.); (Yi, D.); (Yang, J-Y.); (Huang, T-H); (Yen, C-J.); (Tan, M); (Xing, G); (Zhao, Y); (Lin, C-H); (Tsai, S-F); (Fidler, I. J.); 洪明奇(Mien-Chie Hung)* |
| 中國醫藥大學 |
2010 |
ARD1 stalization of TSC2 suppresses tumorigenesis via the mTOR signaling pathway
|
(Kuo, H-P); (Lee, D-F); (Chen, C-T.); (Liu, M.); (Chou, C-K.); (Lee, H. J.); (Xie, X.); (Wei, Y.); (Xia, W); (Zhang, W.); (Yi, D.); (Yang, J-Y.); (Huang, T-H); (Yen, C-J.); (Tan, M); (Xing, G); (Zhao, Y); (Lin, C-H); (Tsai, S-F); (Fidler, I. J.); 洪明奇(Mien-Chie Hung)* |
| 亞洲大學 |
2004-11 |
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis.
|
Li, Y. M.;Pan, Y.;Wei, Y.;Cheng, X.;Zhou, B.;Tan, M.;Zhou, X.;Xia, W.;Hortobagyi, G. N.;Yu, D.;Mien-Chie Hung |
| 亞洲大學 |
2004-04 |
PTEN activation contributes to tumor inhibition by trastuzumab and loss of PTEN predicts trastuzumab resistance in patients
|
Nagata, Y.;Lan, K-H.;Zhou, X.;Tan, M.;Esteva, F. J.;Sahin, A. A.;Klos, K. S.;Li, P.;Monia, B. P.;Nguyen, N. T.;Hortobagyi, G. N.;Mien-Chie Hung;Yu, D. |
顯示項目 26-36 / 36 (共2頁)
<< < 1 2
每頁顯示[10|25|50]項目
|
